IBDEI3AX ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,295,0)
 ;;=OBSESSIVE-COMPULSIVE & RELATED DISORDERS^19^42
 ;;^UTILITY(U,$J,358.4,296,0)
 ;;=PERSONAL HX & CURRENT CIRCUMSTANCES^22^42
 ;;^UTILITY(U,$J,358.4,297,0)
 ;;=COUNSELING/MEDICAL ADVICE^5^42
 ;;^UTILITY(U,$J,358.4,298,0)
 ;;=SOCIAL ENVIRONMENT PROBLEMS^29^42
 ;;^UTILITY(U,$J,358.4,299,0)
 ;;=PARAPHILIC DISORDERS^21^42
 ;;^UTILITY(U,$J,358.4,300,0)
 ;;=PERSONALITY DISORDERS^23^42
 ;;^UTILITY(U,$J,358.4,301,0)
 ;;=CRIME/LEGAL SYSTEM PROBLEMS^6^42
 ;;^UTILITY(U,$J,358.4,302,0)
 ;;=PSYCHOSOCIAL/PERSONAL/ENVIRONMENTAL^24^42
 ;;^UTILITY(U,$J,358.4,303,0)
 ;;=RELATIONAL PROBLEMS^25^42
 ;;^UTILITY(U,$J,358.4,304,0)
 ;;=SCHIZOPHRENIA/OTH PSYCHOTIC DISORDERS^26^42
 ;;^UTILITY(U,$J,358.4,305,0)
 ;;=SEXUAL DYSFUNCTIONS^27^42
 ;;^UTILITY(U,$J,358.4,306,0)
 ;;=SLEEP-WAKE DISORDERS^28^42
 ;;^UTILITY(U,$J,358.4,307,0)
 ;;=SUBSTANCE DISORDER-ALCOHOL^31^42
 ;;^UTILITY(U,$J,358.4,308,0)
 ;;=SUBSTANCE DISORDER-CANNABIS^33^42
 ;;^UTILITY(U,$J,358.4,309,0)
 ;;=SUBSTANCE DISORDER-HALLUCINOGEN^34^42
 ;;^UTILITY(U,$J,358.4,310,0)
 ;;=SUBSTANCE DISORDER-OPIOID^36^42
 ;;^UTILITY(U,$J,358.4,311,0)
 ;;=SUBSTANCE DISORDER-SEDATIVE/HYPNOTIC^37^42
 ;;^UTILITY(U,$J,358.4,312,0)
 ;;=SUBSTANCE DISORDER-TOBACCO^39^42
 ;;^UTILITY(U,$J,358.4,313,0)
 ;;=TRAUMA/STRESSOR-RELATED DISORDERS^42^42
 ;;^UTILITY(U,$J,358.4,314,0)
 ;;=SUBSTANCE DISORDER-INHALANT^35^42
 ;;^UTILITY(U,$J,358.4,315,0)
 ;;=CLINICAL RESEARCH PROGRAM^4^42
 ;;^UTILITY(U,$J,358.4,316,0)
 ;;=SOMATIC SYMPTOM & RELATED DISORDERS^30^42
 ;;^UTILITY(U,$J,358.4,317,0)
 ;;=DISRUPTIVE,IMPULSE,CONDUCT D/O^8^42
 ;;^UTILITY(U,$J,358.4,318,0)
 ;;=ELIMINATION DISORDERS^11^42
 ;;^UTILITY(U,$J,358.4,319,0)
 ;;=GAMBLING DISORDER^13^42
 ;;^UTILITY(U,$J,358.4,320,0)
 ;;=OTHER MENTAL DISORDERS^20^42
 ;;^UTILITY(U,$J,358.4,321,0)
 ;;=NEURODEVELOPMENTAL DISORDERS^18^42
 ;;^UTILITY(U,$J,358.4,322,0)
 ;;=SUBSTANCE DISORDER-CAFFEINE^32^42
 ;;^UTILITY(U,$J,358.4,323,0)
 ;;=SUICIDAL IDEATIONS/ATTEMPTS^41^42
 ;;^UTILITY(U,$J,358.4,324,0)
 ;;=SUBSTANCE DISORDER-UNKNOWN SUBSTANCE^40^42
 ;;^UTILITY(U,$J,358.4,325,0)
 ;;=SUBSTANCE DISORDER-STIMULANTS^38^42
 ;;^UTILITY(U,$J,358.4,326,0)
 ;;=UNDERDOSING OF MEDICATION REGIMEN^43^42
 ;;^UTILITY(U,$J,358.4,327,0)
 ;;=ESTABLISHED PATIENT^1^43
 ;;^UTILITY(U,$J,358.4,328,0)
 ;;=CARE PLAN OVERSIGHT^1^44
 ;;^UTILITY(U,$J,358.4,329,0)
 ;;=OTHER SERVICES^4^44
 ;;^UTILITY(U,$J,358.4,330,0)
 ;;=CASE MANAGEMENT^2^44
 ;;^UTILITY(U,$J,358.4,331,0)
 ;;=EDUCATION^3^44
 ;;^UTILITY(U,$J,358.4,332,0)
 ;;=CARDIOVASCULAR DISORDERS^1^45
 ;;^UTILITY(U,$J,358.4,333,0)
 ;;=CONDITIONS AFFECTING HEALTH CARE STATUS^2^45
 ;;^UTILITY(U,$J,358.4,334,0)
 ;;=DIABETES^4^45
 ;;^UTILITY(U,$J,358.4,335,0)
 ;;=EYE & EAR DISORDERS^4^45
 ;;^UTILITY(U,$J,358.4,336,0)
 ;;=MENTAL HEALTH^5^45
 ;;^UTILITY(U,$J,358.4,337,0)
 ;;=NEOPLASMS^6^45
 ;;^UTILITY(U,$J,358.4,338,0)
 ;;=NEUROLOGICAL CONDITIONS^7^45
 ;;^UTILITY(U,$J,358.4,339,0)
 ;;=OTHER CONDITIONS^8^45
 ;;^UTILITY(U,$J,358.4,340,0)
 ;;=RESPIRATORY DISORDERS^9^45
 ;;^UTILITY(U,$J,358.4,341,0)
 ;;=DEMENTIA^3^45
 ;;^UTILITY(U,$J,358.4,342,0)
 ;;=AUDIOLOGIC FUNCTION TESTS^1^46
 ;;^UTILITY(U,$J,358.4,343,0)
 ;;=SCREENING^10^46
 ;;^UTILITY(U,$J,358.4,344,0)
 ;;=COCHLEAR IMPLANT^2^46
 ;;^UTILITY(U,$J,358.4,345,0)
 ;;=OTHER TREATMENT^7^46
 ;;^UTILITY(U,$J,358.4,346,0)
 ;;=DISPENSING^4^46
 ;;^UTILITY(U,$J,358.4,347,0)
 ;;=REMOVAL FOREIGN BODY/CERUMEN^9^46
